Cutting Costs of Monoclonal Antibodies for Biological Drugs against Covid-19 and Cancer
Biotech & Health
Proteins in biopharmaceutical productions are usually separated and purificated through the expensive chromatography technique. European researchers are developing an innovative membrane crystallization technology to overcome the issue and make the production of monoclonal antibodies more efficient
